Core Viewpoint - EyePoint Pharmaceuticals has granted stock options to new employees as inducement awards outside its 2023 Long-Term Incentive Plan, in compliance with NASDAQ Listing Rule 5635(c)(4) [1][2]. Company Overview - EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for serious retinal diseases [3]. - The company's lead product candidate, DURAVYU™, is a sustained delivery treatment combining vorolanib, a selective tyrosine kinase inhibitor, with next-generation bioerodible Durasert E™ technology [3]. - DURAVYU is currently undergoing evaluation in two Phase 3 pivotal trials for wet age-related macular degeneration (wet AMD), with topline data for the LUGANO trial expected in mid-2026 [3]. - The first patient dosing in pivotal Phase 3 clinical trials for diabetic macular edema (DME) is anticipated in the first quarter of 2026 [3]. Stock Options Details - The company granted stock options to purchase up to 31,000 shares of common stock to seven new employees on November 14, 2025 [2]. - The exercise price for the options is set at $11.58 per share, which is the closing price of EyePoint's common stock on the grant date [2]. - The options have a ten-year term and vest over four years, with 25% vesting on the first anniversary and the remainder vesting in equal monthly installments over the following three years [2].

Core Points - Dave & Buster's Entertainment, Inc. announced the granting of stock options and performance stock units to Tarun Lal as part of his inducement to join the company as CEO [1][2] - The awards were approved by the Board under Nasdaq corporate governance rules and were granted on July 15, 2025 [1][2] Summary by Category Stock Options - Mr. Lal was granted a total of 124,766 stock options that will vest annually over three years from the grant date [2] - An additional 124,766 options will vest if the company's stock price doubles before February 1, 2028, contingent on Mr. Lal's continued employment [2] - Further, 83,177 options will vest if the stock price triples before February 1, 2028, also subject to continued employment [2] - An additional 31,191 options will vest annually over three years, conditioned on Mr. Lal purchasing $1,000,000 of the company's common stock by December 31, 2026 [2] Performance Stock Units (PSUs) - Mr. Lal was granted 124,766 PSUs that will be earned upon achieving same store sales growth metrics and will vest annually over two years [2] - Another 124,766 PSUs will be earned and vested based on achieving specific 2027 Adjusted EBITDA, average same store sales growth, and relative TSR metrics [2] Company Overview - Founded in 1982, Dave & Buster's operates 236 venues across North America, offering entertainment and dining experiences [3] - The company has 175 Dave & Buster's branded stores in 43 states, Puerto Rico, and Canada, providing a full menu and various entertainment attractions [3] - Additionally, the company operates 61 Main Event branded stores in 22 states, featuring bowling, laser tag, arcade games, and virtual reality experiences [3]

Core Points - The stock option grants aim to align the long-term interests of the board members with those of the Company [2] - Four independent board directors received stock option grants allowing the purchase of up to 24,784 shares each [1] - The exercise price for the stock options is set at USD 9.28 per share [5] Summary by Sections Stock Option Grants - The stock options are part of the Company's Equity Incentive Plan approved on June 13, 2022 [2] - The options are subject to a three-year vesting period, with one-third vesting each year starting from the AGM where the options were awarded [5] - The options can only be exercised if the grantee remains a board member at the time of vesting [5] Financial Details - The exercise price is determined by the opening price of the Company's ordinary shares on the Nasdaq on the grant date, which is June 25, 2025 [3] - Filings related to the vested RSUs of the independent board directors have been made with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) [2]